Filing Details

Accession Number:
0001104659-10-013792
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-11 12:00:00
Reporting Period:
2010-03-09
Filing Date:
2010-03-11
Accepted Time:
2010-03-11 18:33:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1131324 Genomic Health Inc GHDX Services-Medical Laboratories (8071) 770552594
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201580 D Samuel Colella C/O Versant Ventures
3000 Sand Hill Road, #4-210
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-03-09 55,577 $19.63 2,136,573 No 4 S Indirect Versant Venture Capital I, L.P.
Common Stock Disposition 2010-03-09 1,090 $19.63 41,904 No 4 S Indirect Versant Side Fund I, L.P.
Common Stock Disposition 2010-03-09 1,075 $19.63 41,337 No 4 S Indirect Versant Affiliates Fund I-A, L.P.
Common Stock Disposition 2010-03-09 2,258 $19.63 86,808 No 4 S Indirect Versant Affiliates Fund I-B, L.P.
Common Stock Disposition 2010-03-10 43,257 $19.21 2,093,316 No 4 S Indirect Versant Venture Capital I, L.P.
Common Stock Disposition 2010-03-10 848 $19.21 41,056 No 4 S Indirect Versant Side Fund I, L.P.
Common Stock Disposition 2010-03-10 837 $19.21 40,500 No 4 S Indirect Versant Affiliates Fund I-A, L.P.
Common Stock Disposition 2010-03-10 1,758 $19.21 85,050 No 4 S Indirect Versant Affiliates Fund I-B, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Versant Venture Capital I, L.P.
No 4 S Indirect Versant Side Fund I, L.P.
No 4 S Indirect Versant Affiliates Fund I-A, L.P.
No 4 S Indirect Versant Affiliates Fund I-B, L.P.
No 4 S Indirect Versant Venture Capital I, L.P.
No 4 S Indirect Versant Side Fund I, L.P.
No 4 S Indirect Versant Affiliates Fund I-A, L.P.
No 4 S Indirect Versant Affiliates Fund I-B, L.P.
Footnotes
  1. The Reporting Person is a managing member of Versant Ventures I, LLC ("VVI-LLC"), which is the general partner of each of Versant Side Fund I, L.P., Versant Venture Capital I, L.P., Versant Affiliates Fund I-A, L.P., and Versant Affiliates Fund I-B, L.P. (collectively, the "Versant Funds"). As such, the Reporting Person shares voting and investment power over the shares held by the Versant Funds and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such shares held by the Versant Funds, except to the extent of his proportionate pecuniary interest therein, if any.
  2. Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $19.34 to $20.10 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $19.07 to $19.52 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.